Next Article in Journal
Comparative Analysis of Different Serological and Molecular Tests for the Detection of Small Ruminant Lentiviruses (SRLVs) in Belgian Sheep and Goats
Next Article in Special Issue
Engineering RNA Virus Interference via the CRISPR/Cas13 Machinery in Arabidopsis
Previous Article in Journal
Antiviral RNA Interference Activity in Cells of the Predatory Mosquito, Toxorhynchites amboinensis
Previous Article in Special Issue
CRISPRStudio: A User-Friendly Software for Rapid CRISPR Array Visualization
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 10
Issue 12
10.3390/v10120695
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Anti-CRISPR-Based and CRISPR-Based Genome Editing of Sulfolobus islandicus Rod-Shaped Virus 2

by
David Mayo-Muñoz
†,
Fei He
†,
Jacob Bruun Jørgensen
,
Poul Kári Madsen
,
Yuvaraj Bhoobalan-Chitty
and
Xu Peng
*
Danish Archaea Centre, Department of Biology, University of Copenhagen, Ole Maaløes Vej 5, 2200 Copenhagen, Denmark
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to the work.
Viruses 2018, 10(12), 695; https://doi.org/10.3390/v10120695
Received: 14 November 2018 / Revised: 5 December 2018 / Accepted: 6 December 2018 / Published: 8 December 2018
(This article belongs to the Special Issue Applications of CRISPR Technology in Virology 2018)
Browse Figures
Versions Notes

Abstract

:
Genetic engineering of viruses has generally been challenging. This is also true for archaeal rod-shaped viruses, which carry linear double-stranded DNA genomes with hairpin ends. In this paper, we describe two different genome editing approaches to mutate the Sulfolobus islandicus rod-shaped virus 2 (SIRV2) using the archaeon Sulfolobus islandicus LAL14/1 and its derivatives as hosts. The anti-CRISPR (Acr) gene acrID1, which inhibits CRISPR-Cas subtype I-D immunity, was first used as a selection marker to knock out genes from SIRV2M, an acrID1-null mutant of SIRV2. Moreover, we harnessed the endogenous CRISPR-Cas systems of the host to knock out the accessory genes consecutively, which resulted in a genome comprised solely of core genes of the 11 SIRV members. Furthermore, infection of this series of knockout mutants in the CRISPR-null host of LAL14/1 (Δarrays) confirmed the non-essentiality of the deleted genes and all except the last deletion mutant propagated as efficiently as the WT SIRV2. This suggested that the last gene deleted, SIRV2 gp37, is important for the efficient viral propagation. The generated viral mutants will be useful for future functional studies including searching for new Acrs and the approaches described in this case are applicable to other viruses.

Graphical Abstract

1. Introduction

Viruses are recognized as the most abundant biological entities on Earth. There are an estimated 1031 viruses on the planet [1] which outnumber their hosts by approximately tenfold in most environments [2,3]. Metagenomics has shown the great diversity of viral communities. There are possibly 500 different viral genotypes in 200 L of seawater and around one million different viral genotypes in 1 kg of marine sediment [4]. However, viruses are still poorly understood with most of their genes having an unknown function and showing little or no sequence similarity to genes in databases [5]. Even though structural, transcriptomic, and proteomic studies have shed some insight into the molecular mechanisms of the virus life cycle, efficient genetic manipulation is of great importance to facilitate the functional characterization of many of these viral genes.
In general, genetic engineering of viruses is challenging. While non-lytic viruses can be manipulated relatively easily by the introduction of a selection marker so that the host carrying the recombinant viral genome survives the selection, for lytic viruses, only markers that are essential for their propagation can be used for the genetic manipulation. For example, Escherichia coli trxA and cmk genes are required for T7 phage propagation but not for host growth and they both can be used as markers for T7 phage engineering [6]. Only T7 phages that acquired the marker gene can propagate in a host lacking the respective marker gene. However, these markers are scarce and only identified in a few well-studied phages. To circumvent this, the Bacteriophage Recombineering of Electroporated DNA (BRED) strategy was employed for the manipulation of lytic mycobateriophage [7,8]. In this case, BRED phage DNA and a targeting template (either ssDNA or dsDNA with homologous arms flanking the mutation sites of phage) are co-electroporated into a host. Furthermore, phage-derived recombinases are exploited to induce high levels of homologous recombination between the phage genome and the targeting template. However, this system is hard to use in strains refractory to electroporation. For archaeal viruses, genetic engineering becomes even more crucial since they exhibit great genetic diversity and only an extremely low percentage of their genes have detectable homologs in public databases [9,10]. In previous studies, tedious methods such as long inverse PCR (LIPCR) [11,12,13,14], transposon mutagenesis [11,14], or infectious clones [15] have been used for the construction of viral mutants in Sulfolobus spindle-shaped virus (SSV) and Sulfolobus turreted icosahedral virus (STIV). Both of these viruses have circular dsDNA genomes.
More recently, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and their associated genes (cas) systems have come into play. CRISPR-Cas constitutes a widely-spread adaptive immune system in bacteria and archaea [16,17]. CRISPR loci consist of several cas genes and arrays of short repeats separated by variable sequences originated from mobile genetic elements especially viruses and plasmids. crRNAs expressed from the CRISPR arrays form effector complexes together with Cas proteins, which guide them for invader silencing [18,19]. CRISPR-Cas systems especially type II (Cas9) have been harnessed for genetic engineering of many organisms such as bacteria, yeast, plants, and animals. In the first attempt, E. coli subtype I-E CRISPR-Cas system was used to generate a deletion of two genes from T7 phage genome [20]. In addition, type II CRISPR-Cas system has also been exploited for genetic manipulation of viruses. In one case, CRISPR-Cas9 was reported to be a valuable tool for non-integrating adenoviral gene deletion and exchange [21]. Subtype II-A CRISPR-Cas system from Streptococcus thermophiles was also used for point mutation, deletion, and gene swap in Streptococcus phage 2972 [22].
In this scenario, we report on two different approaches for editing the genome of an archaeal virus known as the Sulfolobus islandicus rod-shaped virus 2 (SIRV2), which carries a linear dsDNA of 35,498 bp with covalently-closed ends and encodes 54 genes [23,24,25]. The first approach involves an anti-CRISPR (Acr) protein as a selection marker while the second approach was marker-less by harnessing the host endogenous CRISPR-Cas for editing. Acrs have been discovered in a number of viruses to date from several narrow groups of bacteria and archaea such as Pseudomonas, Listeria, Streptococcus, Moraxella, and Sulfolobus. Forty different families of Acr proteins have been found against CRISPR-Cas subtypes I-C, I-D, I-E, I-F, II-A, II-C, and V-A [26,27,28,29,30,31,32,33,34,35,36], mostly by using a guilt-by-association bioinformatics approach based on anti-CRISPR-associated genes [30]. AcrID1 (SIRV2 gp03 and SIRV3 gp02) is the first example of Acr found in the archaea domain and the first against CRISPR-Cas type I-D system [29]. In this work, acrID1 was exploited as a selection marker to delete non-essential or essential genes in the viral genome.
This research paper consists of two major parts. The first part involves gene knockout from SIRV2M, an acrID1-null mutant of SIRV2 [29], using acrID1 (SIRV3 gp02) as a selection marker in the Sulfolobus host carrying CRISPR-Cas type I-D immunity. In the second part, we knocked out consecutively the accessary genes from another mutant of SIRV2 using a CRISPR-based genome editing method and obtained a knockout mutant that carries only the core genome of the 11 SIRVs known as SIRV1–SIRV11 [37]. The infectivity of the different viral mutants was also studied.

2. Material and Methods

2.1. Strains and Growth Conditions

Sulfolobus islandicus LAL14/1 and its derivatives carrying pyrF deletion (ΔpyrF) [38] and all five CRISPR arrays deletion (Δarrays) [38] were used for infection and transformation. E. coli DH5α was used for cloning of the plasmids.
Sulfolobus cells were grown aerobically at 78 °C and 150 rpm in a GCVY medium, which contains basic salts medium [39] supplemented with 0.2% glucose, 0.2% casamino acids, 0.005% yeast extract, and a vitamin mixture or SCV medium containing basic salts medium supplemented with 0.2% sucrose, 0.2% casamino acids, and a vitamin mixture. Uracil (20 μg/mL) was added to the medium for the cultivation of the ΔpyrF strains. Transformed E. coli cells were grown overnight at 37 °C in LB (Luria–Bertani broth) agar supplemented with 100 μg/mL ampicillin. Single colonies were inoculated into 20 mL of LB media supplemented with 100 μg/mL ampicillin and grown overnight at 37 °C and 200 rpm.

2.2. Cloning

All gene fragments were amplified by using PCR or fusion PCR with a Phusion Hot Start II DNA Polymerase (2 U/µL) (F549L, Thermo Scientific™, Waltham, MA, USA) and primers listed in Table S1. All primers and spacers were ordered as ssDNA (Integrated DNA Technologies, Inc., Coralville, IA, USA) and are listed in Table S1. PCR products were analyzed by using agarose gel electrophoresis. PCR or digested products were purified using the GeneJET PCR Purification Kit (K0702, Thermo Scientific™). Digested fragments and vectors were ligated using the T4 DNA ligase kit (5 U/µL) (EL0011, Thermo Scientific™), according to the manufacturer’s instructions. The ligated DNAs were transformed into E. coli DH5α, analyzed by colony PCR using Taq DNA Polymerase and plasmid clones, which were purified using the Plasmid DNA Mini Kit I (D6943-02, Omega, Norcross, USA). The inserts of the resultant clones were analyzed by using PCR, which was followed by DNA sequencing (Eurofins Genomics, Ebersberg, Germany).

2.3. Construction of Anti-CRISPR-Based Genome Editing Plasmids

First, we constructed the pJET1.2 vectors with homologous flanking arms. Second, the acrID1 marker was digested with NheI and KpnI restriction enzymes (ER0971, ER0521, Thermo Scientific™) and inserted between the homologous flanking arms in pJET1.2, which yielded pJET1.2 plasmids listed in Table S1. SIRV2 gp49 was cloned into pEXA2 [40] for its expression.

2.4. Construction of CRISPR-Based Genome Editing Plasmids

CRISPR-based genome-editing plasmids (Table S1) were constructed individually by cloning a mini-CRISPR array carrying a single spacer and a deletion mutant allele of the target gene into the basic genome-editing plasmid pGE1 [38]. pGE1 contains LguI restriction sites that were oppositely oriented and flanked by two CRISPR type I-A repeats as well as PaeI-XhoI restriction sites for the insertion of homologous recombination sequences. crRNA generated from the mini-CRISPR array can be used by type III effector complexes [41]. Additionally, for selective purposes, it contains a uracil synthesizing gene [42].
First, a protospacer is identified in the gene of interest, which will be targeted by the CRISPR-Cas immune system once the corresponding crRNA is provided. It is important to consider that type III systems function only when the crRNA is complementary to a transcript. Under these circumstances, a protospacer—39 nt long—on the template strand of the target gene was selected. Afterwards, a spacer was constructed based on the selected protospacer of the target gene by mixing two complementary oligonucleotides (Table S1), which was followed by heating at 95 °C for 10 min and subsequently cooling down gradually to room temperature. The resulting dsDNA carrying 3 nt protruding ends—AAC and AGC—was ligated into the LguI site of the linearized pGE1 (FD1934, Thermo Scientific™), which yielded plasmids carrying a mini-CRISPR array.
Respective donor DNA fragments containing the expected deletion mutant allele of each target gene were obtained by using overlap extension PCR [43] from a SIRV2MII (Table 1) template. The primers were designed for PCR amplification of two homologous DNA sequences (left and right arms) flanking the target gene from the viral genome and, crucially, did not include the protospacer. After fusion of both arms, the PCR products were digested with PaeI and XhoI restriction enzymes (FD0604, FD0694, Thermo Scientific™) and purified again. In the case of target genes that are adjacent in the genome—e.g., gp10, gp11, and gp12— a donor DNA was designed for the deletion of all of them at a time. It is fundamental to consider maintaining intact promoters and terminators of neighboring genes that might be within the target gene sequence. The resulting restriction DNA fragments were inserted into their cognate mini-CRISPR array plasmids at the same site, which gave rise to pGE1 constructs listed in Table S1.

2.5. Electroporation Procedure

Electroporation was used to transform S. islandicus with each pJET1.2-based or pGE1-based construct, according to a procedure described previously [44], with the following modifications: (1) all manipulations were carried out at room temperature, (2) after electroporation of 500 ng DNA into 50 μL Sulfolobus competent cells (OD600 around 10), the cells were immediately transferred into 950 μL pre-warmed basic salts medium (pre-mixed with SIRV2M, MOI of 1, only in the case of pJET1.2 transformation) and incubated at 75 °C for 30 min without shaking, and (3) 100 μL of cells were mixed with 5 mL of 2x SCV and 5 mL 0.4% Gelrite®and plated onto pre-warmed 1.4% Gelrite® (71010-52-1; Roth) plates containing 2x SCV medium. After the top layer was set, the plates were put into a tightly closed plastic box, and incubated at 78 °C for five to seven days.

2.6. Construction of Knockout Mutants and Knockout Screening by PCR

In the case of the CRISPR-based genome editing, the cells transformed with knockout plasmids were grown in SCV medium (containing no uracil for the selection of the plasmids) and were infected with the corresponding virus for genome editing. The cultures were grown from OD600 0.1 for 1 h and infected with 10 µL of the previous deletion mutant for the next gene knockout. After 48 h of infection, viruses were harvested by centrifuging at 10,000× g for 6 min and the supernatant was diluted 106 times into fresh Δarrays cells carrying the corresponding genome editing plasmid. The process was repeated 4 to 5 times for complete removal of the WT virus.
All deletion mutants were screened by PCR amplification of the WT target gene and its mutated allele by using primers listed in Table S1. The resulting PCR products were analyzed by agarose gel electrophoresis and by DNA sequencing (Eurofins Genomics, Ebersberg, Germany).

2.7. Plaque Assay

Three mL of LAL14/1 Δarrays cells (OD600 around 0.2) were premixed with serial dilutions of the corresponding virus and incubated at 78 °C and 150 rpm for 30 min. The infected cultures were then mixed with 3 mL of 0.4% Gelzan™ CM (Gelrite®, G1910, Merck KGaA, Darmstadt, Germany) and plated onto pre-warmed 1.4% Gelzan plates containing 2x SCV medium. After the top layer was set, the plates were put into a plastic box, tightly closed, and incubated at 78 °C for two days. The observed circular zones of clearing (plaques) were due to viral replication and lysis of the Sulfolobus host. The plaque forming units (PFU) were calculated from the plates containing a quantifiable number of plaques.

3. Results and Discussion

3.1. Knockout of a Non-Essential Gene (SIRV2 Gp29) and an Essential Gene (SIRV2 Gp49) from SIRV2M Genome Using AcrID1 as a Selection Marker

We reported recently that acrID1 flanked with recombination arms can be inserted into the SIRV2M genome to evade the CRISPR-Cas I-D immunity [29]. In accordance, the first part of this work was to test whether acrID1 could be used as a selection marker to knock out genes from the SIRV2M genome. To this end, we randomly selected a non-essential gene (SIRV2 gp29) and an essential gene (SIRV2 gp49) for the knockout [44,45].
The SIRV2 gp29, which is an ORF encoding 156 amino acids, is not part of the core genome of the 11 SIRV members known as SIRV1-SIRV11 (PMID:28534836) [37] and, thus, is likely to be non-essential for viral propagation. As depicted in Figure 1A, a PCR product containing acrID1 flanked by the upstream (495 bp) and downstream (441 bp) sequences of gp29 was cloned into the bacterial plasmid pJET1.2, which does not replicate in S. islandicus. The plasmid was electroporated into LAL14/1 ΔpyrF, which carries all the wild type CRISPR-Cas systems including the I-D immunity [38]. SIRV2M was added immediately, which was followed by incubation at 78 °C for two days. Potential knockout of gp29 through recombination between the homologous sequences of the plasmid and the SIRV2M genome (Figure 1A) was monitored by PCR amplification of the SIRV2 gp29 region using virion DNA in culture supernatant as a template, which revealed a substitution of gp29 with acrID1 (Figure 1B, left panel). The culture supernatants were then diluted 1000 times into fresh LAL14/1 ΔpyrF cells and PCR was performed again after two days of incubation (Figure 1B, right panel). This indicated that the recombinant virus quickly became predominant and was maintained at a stable condition. To obtain the pure gp29 deletion mutant (Δgp29), the culture supernatant was then diluted 1000 times into fresh LAL14/1 ΔpyrF cells for two more rounds and the viral purity was checked by PCR amplification. No band was detected with the primers located inside the gp29 gene indicating the high purity of the mutant virus (Figure 1C). Thus, we succeeded to exploit acrID1 as a selection marker for the knockout of an inessential gene.
Next, we attempted to knock out an essential gene. SIRV2 gp49 (ORF98) encodes the only protein component of virus-associated pyramids (VAPs), which are assembled on the host cell surface and open up at the final stage of infection to facilitate the release of virus particles [46,47]. Accordingly, the VAP protein gp49 is considered to be essential for the lytic virus life cycle. In order to knock out this gene, we introduced a plasmid-borne gp49 into LAL14/1 ΔpyrF where gp49 was placed under the control of a highly strong promoter known as the csa5 promoter from the host [48]. This ensures the availability of enough VAP protein before the knockout takes place. The gp49-containing LAL14/1 ΔpyrF cells (LAL14/1 ΔpyrF/pgp49) were then used to knock out gp49 from SIRV2M using the same strategy that was applied to the previously mentioned knockout of gp29 (Figure 2A). As shown in Figure 2B, the recombination between the acrID1-containing plasmid and SIRV2M genome was already detectable two days post electroporation of the plasmid and the addition of SIRV2M in the culture (left panel). Moreover, as with the gp29 knockout, the recombinant virus remained stable after a 1000 times dilution into fresh cultures (right panel). PCR involving one primer derived from the gp49 sequence demonstrated that a pure gp49 knockout viral strain (Δgp49) was obtained after two more rounds of a 1000 fold dilution of the virus into fresh cultures (Figure 2C).
The infectivity of SIRV2MΔgp29 and SIRV2MΔgp49 were then tested in LAL14/1 ΔpyrF, which carries the wild type CRISPR-Cas systems. Due to the insertion of acrID1, SIRV2MΔgp29 gained the infectivity in LAL14/1 (Figure 3A), which also demonstrated the inessentiality of gp29. However, gp49 appeared to be essential for the lytic life cycle of the virus since SIRV2MΔgp49 is not able to cause growth retardation of the host cells (Figure 3A) unless a plasmid-borne gp49 was provided (Figure 3B).

3.2. CRISPR-Based Viral Genome Editing Approach

Even though the previously mentioned knockout approach is efficient, it leaves the selection marker acrID1 in the recombinant viral genome, which makes it difficult for consecutive deletions of other genes. Previously, CRISPR-Cas systems were harnessed for genome editing in the model archaeon Sulfolobus [41], but, so far, no CRISPR-based genome editing approach has been applied to archaeal viruses. Recently, SIRV2 gp48, which is a non-core gene of the 11 SIRVs, was deleted from SIRV2M for a comprehensive functional study (Bhoobalan-Chitty et al., in preparation) from which we initiated the CRISPR-based consecutive gene deletions.
The CRISPR-based viral genome editing procedure is depicted in Figure 4. First, two DNA components were cloned into a plasmid. One is a mini-CRISPR array with a spacer targeting the gene to be deleted and the other is a donor DNA with two homologous regions to the viral genome flanking the target gene. Second, the plasmid was transformed into the CRISPR-null host of LAL14/1, Δarrays, and, therefore, the only crRNA is derived from the plasmid-borne mini-CRISPR array. Subsequently, upon viral infection into the transformant, the viral DNA recombined with the donor DNA and the recombinant virus, which has gained a non-target allele, was selectively retained while the input virus was killed due to the presence of a protospacer.

3.3. Consecutive Knockout of SIRV2 Accessory Genes

A total of 23 genes have been identified as accessory genes in the SIRV2 genome on the basis that they do not form part of the core genome of Sulfolobus islandicus rod-shaped viruses, which are known as SIRV1-SIRV11 [37]. A 4 kb deletion in the left near-terminus spanning the SIRV2 gp02 to gp09 genes was reported recently [29]. The resultant viral mutant, SIRV2M, carries another deletion of a 1.5 kb fragment at the right near-terminus spanning the non-core gp51 to gp53 genes, which was revealed by PCR amplification of this genomic region (Table 1). Consequently, after deletion of gp48 (Bhoobalan-Chitty, in preparation), the viral genome was left with 11 accessory genes: gp10 (ORF105a), gp11 (ORF62a), gp12 (ORF102), gp22 (ORF91), gp23 (ORF158b), gp29 (ORF156), gp37 (ORF114), gp45 (ORF94), gp46 (ORF95), gp47 (ORF112), and gp50 (ORF73). Eleven of the SIRVs core genes (black-colored arrows in Figure 5) have no detectable homologs in the genome of the distant member of the Rudiviridae, Acidianus rod-shaped virus (ARV) and five of these lack detectable homologs in another member known as the Stygiolobus rod-shaped virus (SRV). This might be due to sequence divergence and were, therefore, not considered for knockout. In addition, since gp25 (ORF76) is an ORF that overlaps gp26 and its expression is extremely low during the entire infection cycle [49,50], it might not be a gene and, therefore, was not considered for knockout (white-colored arrows in Figure 5).
In this part, we explored the CRISPR-based genome editing to knock out the accessory genes one after another. After completion of a gene knockout, the resultant viral deletion mutant is infected into a new host harboring a plasmid for the knockout of the next gene(s). To ensure the purity of the knockout mutants, we diluted virions present in the culture supernatant 106-fold into fresh Δarrays cells carrying the corresponding genome editing plasmid. This process was repeated four to five times. The knockout mutants were named according to the order they were generated from SIRV2M to SIRV2MVII (Table 1).
Potential recombination events and the purity of the knockout mutants were monitored by PCR amplification of the WT-target gene and its deletion mutant allele uses two sets of primers including one annealing upstream and downstream of the target gene (F5/R5) and a second one annealing in the genomic region within the target gene (F6/R6) (Figure 6A). As a result of the recombination between the viral and the donor DNAs, the target gene is expected to be absent from the knockout mutant. Therefore, the amplified fragments by F5/R5 primers would be shorter than that from the input virus while the F6/R6 primer set would not be able to produce any amplicon. Additionally, subsequent DNA sequencing of the PCR fragments allowed the determination of the precise positions of the deletions.
Figure 6B shows the results from PCRs performed using the last deletion mutant (“b” lanes) SIRV2MVII (Table 1) as a template. SIRV2MII which is the starting virus used in this part of the work (Table 1), was used as a positive control (“a” lanes) and water was used as a negative control (“c” lanes). Despite the presence of some minor unspecific bands, all PCR generated major products as expected (Table S2). The genes were knocked out in the following order: gp22–gp23, gp45–gp47, gp50, gp29, and gp37 (Table 1), which were all shown to be present in SIRV2MII and absent in SIRV2MVII (Figure 6B). The three genes, gp10-gp12, were supposed to be knocked out in the end, but we discovered, during the knockout trial, that they were already absent from SIRV2MII and were still present in SIRV2M (“0” lane in the last panel of Figure 6B). Moreover, gp13–gp14, which are part of the SIRVs core genome but absent in ARV and SRV (Figure 5), were found to be absent in SIRV2MII as well (Table 1). It seems that the deletion of gp10–gp14 naturally occurred as was the case for gp02–gp09 and gp51–gp53 in SIRV2M [29]. The successive propagation of the virus in the CRISPR-null hosts, S. solfataricus 5E6 [50] and S. islandicus LAL14/1 ∆arrays, could have promoted the loss of these near-terminus genes.
In order to check whether other spontaneous deletions had occurred in the smallest mutant SIRV2MVII, five PCR fragments spanning the entire genome were amplified (Figure S1) and sequenced. SIRV2MII was also sequenced as a control. Only a few single point mutations but no other gene deletions were revealed (Table S3). The precise positions of the deletions using the SIRV2 genome as a reference are detailed in Table 1. These were also supported by sequencing of the PCR products derived from each knockout mutant using the respective primers F5/R5.
In all except one case, the knockout yielded the expected deletion. However, the deletion of gp22–23 was different from what the donor DNA was designed to achieve. In this case, gp23 was not completely deleted as expected, but, instead, 156 nt at the 5’ end was retained and, unexpectedly, 38 nt at the 3’ end of gp21 was shown to be lost. Even though gp21 is a core gene of SIRVs, no obvious homologs are present in ARV or SRV (Figure 5). It is, therefore, difficult to assess its essentiality. Nevertheless, the deletion of the C-terminal 12 aa did not affect the viral life cycle since the knockout mutant can still propagate in the CRISPR-null host (see below).

3.4. SIRVs’ Core Genome

After the natural and knockout deletions, the SIRV2 genome has been reduced in a total of 25 genes, which is something that translates into more than a 45% reduction in the gene content. The resultant viral genome, SIRV2MVII, is 23849 kb in length, which is less than 70% of the original genome size. Noteworthy, this points toward the notion that a large portion of viral genomes is comprised merely of accessory genes, which are non-essential for their basic life cycle (grey-colored arrows in Figure 5). Morons are additions [51]—more on them—that may optimize the phage to adapt to a certain host or niche. Changing the combination of these genes gives the virus population access to new niches.
The remaining genes form the core genome of the 11 members of SIRVs, which are black and color-coded in the genome maps in Figure 5 even though their essentiality remains to be tested by experimental studies. Their average size is substantially larger than that of accessory genes. A comparison between the smallest deletion mutant obtained in this work and representative members of Rudiviridae family is depicted in Figure 5. The color-coded genes represent the core genes shared by all the members of the family and it is reflected how they are essential for the lytic cycle of the virus under any condition such as genes encoding the components for DNA replication, nucleotide metabolism, and the assembly of the virus.

3.5. Assessing the Effect of The Deletions on Viral Infectivity

We compared the infectivity of SIRV2 and all the deletion mutants by infecting the CRISPR-null host, Δarrays, at a MOI of 0.1 and measuring the amount of virions released at 12 h and 24 h post infection (hpi). Figure 7 shows a similar infectivity for SIRV2 and all the deletion mutants except SIRV2MVII, which exhibited a tenfold reduction of the viral production. A repeated experiment using SIRV2, SIRV2MII, and SIRV2MVII showed a similar result (Figure S2). In addition, the plaques formed by SIRV2MVII were considerably smaller than those from SIRV2MVI and the other tested viruses (Figure S3). Accordingly, it is inferred that the last gene deleted, gp37, is not essential but important for the efficient propagation of the virus in the CRISPR-null host.
SIRV2 gp37 (ORF114) is homologous to proteins encoded by other crenarchaeal viruses including double-stranded DNA genomes, which represent three viral families: Rudiviridae, Lipotrixviridae, and Bicaudaviridae as well as the unclassified Sulfolobus turreted icosahedral virus (STIV). Homologs are clearly identified on genomes of SIRV1 (gp29, ORF114) [23], SIRV3 (gp28, ORF114), Acidianus filamentous viruses AFV1 (ORF116) [52] and AFV3 (gp16, ORF109) [53], STIV (ORFB116) [54], Sulfolobus monocaudavirus SMV4 (gp61, ORF113) [55], and S. islandicus filamentous virus SIFV (ORF118) [56]. STIV B116 and AFV3-109 have been identified as DNA binding proteins even though the DNA target has not yet been identified [57,58]. Wirth et al. [15] showed that STIV B116 could be knocked out but the resultant mutant exhibited smaller plaques and a delayed infection cycle, which indicates that the null mutant is crippled. Despite DNA binding activity of STIV B116, the knockout mutant showed no change in viral transcription patterns, which suggests that B116 is not a regulator of STIV transcription.

4. Conclusions

In this work, acrID1 was repurposed as a selection marker to genetically modify the SIRV2 genome including knocking out one essential gene. Moreover, using the CRISPR-based genome editing approach, we successfully deleted all the remaining accessory genes of SIRV2, which yields a viral genome formed solely by core genes of the 11 SIRV viruses. Both the Acr-based and the CRISPR-based genome editing approaches were shown to be effective while the former required less work in cloning and the latter lacked markers, which makes consecutive knockout possible. The results provide a good basis for the future functional study of SIRV genes including the identification of new Acrs. This work represents the first example of Acr-based and CRISPR-based viral genome editing in the Archaea domain. The concept is applicable to other virus-host systems in both Bacteria and Archaea.

Supplementary Materials

The following are available online at https://www.mdpi.com/1999-4915/10/12/695/s1, Figure S1: PCR amplification of five fragments spanning the entire viral genomes. Figure S2: Replicate for plaquing efficiency assay assessing the effect of the deletions on viral infectivity. Figure S3: SIRV2MVII exhibits an altered phenotype of small plaques, Table S1: Primer list. Table S2: Expected sizes (bp) from PCR amplification presented in Figure 6. Table S3: Mutations identified in the genome of SIRV2MII and SIRV2MVII after whole genome sequencing using primers listed in Table S1.

Author Contributions

Conceptualization, X.P., F.H., and Y.B.-C. Methodology, F.H. and Y.B.-C. Software, D.M.-M. and F.H. Validation, X.P., F.H., Y.B.-C., and D.M.-M. Formal Analysis, D.M.-M., F.H., J.B.J., and P.K.M. Investigation, D.M.-M., F.H., J.B.J., and P.K.M. Data Curation, D.M.-M. and F.H. Writing—Original Draft Preparation, D.M.-M. and F.H. Writing—Review & Editing, X.P. and D.M.-M. Visualization, D.M.-M. and X.P. Supervision, X.P., Y.B.-C., and D.M.-M. Project Administration, X.P. Funding Acquisition, X.P.

Funding

This work was supported by the Danish Council for Independent Research/Technology and Production (grant number DFF–7017-00060) and by the Novo Nordisk Foundation/Hallas-Møller Ascending Investigator Grant (grant number NNF17OC0031154) to X.P. F.H was supported by China Scholarship Council.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hendrix, R.W.; Lawrence, J.G.; Hatfull, G.F.; Casjens, S. The origins and ongoing evolution of viruses. Trends Microbiol. 2000, 8, 504–508. [Google Scholar] [CrossRef]
  2. Suttle, C.A. Marine viruses—Major players in the global ecosystem. Nat. Rev. Microbiol. 2007, 5, 801. [Google Scholar] [CrossRef] [PubMed]
  3. Edwards, R.A.; Rohwer, F. Opinion: Viral metagenomics. Nat. Rev. Microbiol. 2005, 3, 504. [Google Scholar] [CrossRef] [PubMed]
  4. Breitbart, M.; Rohwer, F. Here a virus, there a virus, everywhere the same virus? Trends Microbiol. 2005, 13, 278–284. [Google Scholar] [CrossRef] [PubMed]
  5. Mateu, M.G. Structure and Physics of Viruses: An Integrated Textbook; Springer: Dordrecht, The Netherlands, 2013. [Google Scholar]
  6. Qimron, U.; Marintcheva, B.; Tabor, S.; Richardson, C.C. Genomewide screens for Escherichia coli genes affecting growth of T7 bacteriophage. Proc. Natl. Acad. Sci. USA 2006, 103, 19039–19044. [Google Scholar] [CrossRef] [PubMed][Green Version]
  7. Marinelli, L.J.; Piuri, M.; Swigoňová, Z.; Balachandran, A.; Oldfield, L.M.; van Kessel, J.C.; Hatfull, G.F. BRED5: A simple and powerful tool for constructing mutant and recombinant bacteriophage genomes. PLoS ONE 2008, 3, e3957. [Google Scholar] [CrossRef] [PubMed]
  8. Marinelli, L.J.; Hatfull, G.F.; Piuri, M. Recombineering: A powerful tool for modification of bacteriophage genomes. Bacteriophage 2012, 2, 5–14. [Google Scholar] [CrossRef][Green Version]
  9. Prangishvili, D.; Forterre, P.; Garrett, R.A. Viruses of the Archaea: A unifying view. Nat. Rev. Microbiol. 2006, 4, 837–848. [Google Scholar] [CrossRef]
  10. Prangishvili, D.; Garrett, R.A.; Koonin, E.V. Evolutionary genomics of archaeal viruses: Unique viral genomes in the third domain of life. Virus Res. 2006, 117, 52–67. [Google Scholar] [CrossRef]
  11. Iverson, E.A.; Goodman, D.A.; Gorchels, M.E.; Stedman, K.M. Extreme Mutation Tolerance: Nearly Half of the Archaeal Fusellovirus Sulfolobus Spindle-Shaped Virus 1 Genes Are Not Required for Virus Function, Including the Minor Capsid Protein Gene vp3. J. Virol. 2017, 91, e02406–e02416. [Google Scholar] [CrossRef]
  12. Clore, A.J.; Stedman, K.M. The SSV1 viral integrase is not essential. Virology 2007, 361, 103–111. [Google Scholar] [CrossRef] [PubMed][Green Version]
  13. Iverson, E.; Stedman, K. A genetic study of SSV1, the prototypical fusellovirus. Front. Microbiol. 2012, 3. [Google Scholar] [CrossRef] [PubMed][Green Version]
  14. Goodman, D.A.; Stedman, K.M. Comparative genetic and genomic analysis of the novel fusellovirus Sulfolobus spindle-shaped virus 10. Virus Evol. 2018, 4, vey022. [Google Scholar] [CrossRef] [PubMed]
  15. Wirth, J.F.; Snyder, J.C.; Hochstein, R.A.; Ortmann, A.C.; Willits, D.A.; Douglas, T.; Young, M.J. Development of a genetic system for the archaeal virus Sulfolobus turreted icosahedral virus (STIV). Virology 2011, 415, 6–11. [Google Scholar] [CrossRef] [PubMed][Green Version]
  16. Barrangou, R.; Fremaux, C.; Deveau, H.; Richards, M.; Boyaval, P.; Moineau, S.; Romero, D.A.; Horvath, P. CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007, 315, 1709–1712. [Google Scholar] [CrossRef] [PubMed]
  17. Koonin, E.V.; Makarova, K.S.; Zhang, F. Diversity, classification and evolution of CRISPR-Cas systems. Curr. Opin. Microbiol. 2017, 37, 67–78. [Google Scholar] [CrossRef] [PubMed]
  18. Wiedenheft, B.; Sternberg, S.H.; Doudna, J.A. RNA-guided genetic silencing systems in bacteria and archaea. Nature 2012, 482, 331. [Google Scholar] [CrossRef]
  19. Garrett, R.A.; Vestergaard, G.; Shah, S.A. Archaeal CRISPR-based immune systems: Exchangeable functional modules. Trends Microbiol. 2011, 19, 549–556. [Google Scholar] [CrossRef]
  20. Kiro, R.; Shitrit, D.; Qimron, U. Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system. RNA Biol. 2014, 11, 42–44. [Google Scholar] [CrossRef][Green Version]
  21. Bi, Y.; Sun, L.; Gao, D.; Ding, C.; Li, Z.; Li, Y.; Cun, W.; Li, Q. High-Efficiency Targeted Editing of Large Viral Genomes by RNA-Guided Nucleases. PLoS Pathog. 2014, 10. [Google Scholar] [CrossRef]
  22. Martel, B.; Moineau, S. CRISPR-Cas: An efficient tool for genome engineering of virulent bacteriophages. Nucleic Acids Res. 2014, 43, 9504–9513. [Google Scholar] [CrossRef] [PubMed]
  23. Prangishvili, D.; Arnold, H.P.; Götz, D.; Ziese, U.; Holz, I.; Kristjansson, J.K.; Zillig, W. A novel virus family, the Rudiviridae: Structure, virus-host interactions and genome variability of the sulfolobus viruses SIRV1 and SIRV2. Genetics 1999, 152, 1387–1396. [Google Scholar] [PubMed]
  24. Peng, X.; Blum, H.; She, Q.; Mallok, S.; Brügger, K.; Garrett, R.A.; Zillig, W.; Prangishvili, D. Sequences and replication of genomes of the archaeal rudiviruses SIRV1 and SIRV2: Relationships to the archaeal lipothrixvirus SIFV and some eukaryal viruses. Virology 2001, 291, 226–234. [Google Scholar] [CrossRef] [PubMed]
  25. Martínez-Alvarez, L.; Bell, S.D.; Peng, X. Multiple consecutive initiation of replication producing novel brush-like intermediates at the termini of linear viral dsDNA genomes with hairpin ends. Nucleic Acids Res. 2016, 44, 8799–8809. [Google Scholar] [CrossRef] [PubMed][Green Version]
  26. Pawluk, A.; Bondy-Denomy, J.; Cheung, V.H.W.; Maxwell, K.L.; Davidson, A.R. A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of pseudomonas aeruginosa. mBio 2014, 5. [Google Scholar] [CrossRef] [PubMed]
  27. Marino, N.D.; Zhang, J.Y.; Borges, A.L.; Sousa, A.A.; Leon, L.M.; Rauch, B.J.; Walton, R.T.; Berry, J.D.; Joung, J.K.; Kleinstiver, B.P.; et al. Discovery of widespread Type I and Type V CRISPR-Cas inhibitors. Science 2018, 362, 240–242. [Google Scholar] [CrossRef] [PubMed]
  28. Bondy-Denomy, J.; Pawluk, A.; Maxwell, K.L.; Davidson, A.R. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 2013, 493, 429–432. [Google Scholar] [CrossRef]
  29. He, F.; Bhoobalan-Chitty, Y.; Van, L.B.; Kjeldsen, A.L.; Dedola, M.; Makarova, K.S.; Koonin, E.V.; Brodersen, D.V.; Peng, X. Anti-CRISPR proteins encoded by archaeal lytic viruses inhibit subtype I-D immunity. Nat. Microbiol. 2018, 3, 461–469. [Google Scholar] [CrossRef]
  30. Pawluk, A.; Staals, R.H.J.; Taylor, C.; Watson, B.N.J.; Saha, S.; Fineran, P.C.; Maxwell, K.L.; Davidson, A.R. Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nat. Microbiol. 2016, 1. [Google Scholar] [CrossRef]
  31. Rauch, B.J.; Silvis, M.R.; Hultquist, J.F.; Waters, C.S.; McGregor, M.J.; Krogan, N.J.; Bondy-Denomy, J. Inhibition of CRISPR-Cas9 with Bacteriophage Proteins. Cell 2017. [Google Scholar] [CrossRef]
  32. Hynes, A.P.; Rousseau, G.M.; Lemay, M.L.; Horvath, P.; Romero, D.A.; Fremaux, C.; Moineau, S. An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9. Nat. Microbiol. 2017. [Google Scholar] [CrossRef] [PubMed]
  33. Hynes, A.P.; Rousseau, G.M.; Agudelo, D.; Goulet, A.; Amigues, B.; Loehr, J.; Romero, D.A.; Fremaux, C.; Horvath, P.; Doyon, Y.; Cambillau, C.; Moineau, S. Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins. Nat. Commun. 2018. [Google Scholar] [CrossRef] [PubMed]
  34. Pawluk, A.; Amrani, N.; Zhang, Y.; Garcia, B.; Hidalgo-Reyes, Y.; Lee, J.; Edraki, A.; Shah, M.; Sontheimer, E.J.; Maxwell, K.L.; Davidson, A.R. Naturally Occurring Off-Switches for CRISPR-Cas9. Cell 2016. [Google Scholar] [CrossRef] [PubMed]
  35. Lee, J.; Mir, A.; Edraki, A.; Garcia, B.; Amrani, N.; Lou, H.E.; Gainetdinov, I.; Pawluk, A.; Ibraheim, R.; Gao, X.D.; Liu, P.; Davidson, A.R.; Maxwell, K.L.; Sontheimer, E.J. Potent Cas9 inhibition in bacterial and human cells by new anti-CRISPR protein families. bioRxiv 2018. [Google Scholar] [CrossRef]
  36. Watters, K.E.; Fellmann, C.; Bai, H.B.; Ren, S.M.; Doudna, J.A. Systematic discovery of natural CRISPR-Cas12a inhibitors. Science 2018. [Google Scholar] [CrossRef] [PubMed]
  37. Bautista, M.A.; Black, J.A.; Youngblut, N.D.; Whitaker, R.J. Differentiation and Structure in Sulfolobus islandicus Rod-Shaped Virus Populations. Viruses 2017, 9, 120. [Google Scholar] [CrossRef] [PubMed]
  38. He, F.; Vestergaard, G.; Peng, W.; She, Q.; Peng, X. CRISPR-Cas type I-A Cascade complex couples viral infection surveillance to host transcriptional regulation in the dependence of Csa3b. Nucleic Acids Res. 2016, 45. [Google Scholar] [CrossRef] [PubMed]
  39. Zillig, W.; Arnold, H.P.; Holz, I.; Prangishvili, D.; Schweier, A.; Stedman, K.; She, Q.; Phan, H.; Garrett, R.; Kristjansson, J.K. Genetic elements in the extremely thermophilic archaeon Sulfolobus. Extremophiles 1998, 2, 131–140. [Google Scholar] [CrossRef]
  40. Gudbergsdottir, S.; Deng, L.; Chen, Z.; Jensen, J.V.K.; Jensen, L.R.; She, Q.; Garrett, R.A. Dynamic properties of the Sulfolobus CRISPR/Cas and CRISPR/Cmr systems when challenged with vector-borne viral and plasmid genes and protospacers. Mol. Microbiol. 2011, 79, 35–49. [Google Scholar] [CrossRef]
  41. Li, Y.; Pan, S.; Zhang, Y.; Ren, M.; Feng, M.; Peng, N.; Chen, L.; Liang, Y.X.; She, Q. Harnessing Type I and Type III CRISPR-Cas systems for genome editing. Nucleic Acids Res. 2016, 44, e34. [Google Scholar] [CrossRef]
  42. Peng, N.; Deng, L.; Mei, Y.; Jiang, D.; Hu, Y.; Awayez, M.; Liang, Y.; She, Q. A synthetic arabinose-inducible promoter confers high levels of recombinant protein expression in hyperthermophilic archaeon Sulfolobus islandicus. Appl. Environ. Microbiol. 2012. [Google Scholar] [CrossRef] [PubMed]
  43. Horton, R.M.; Cai, Z.; Ho, S.N.; Pease, L.R. Gene splicing by overlap extension: Tailor-made genes using the polymerase chain reaction. Biotechniques 2013. [Google Scholar] [CrossRef] [PubMed]
  44. Deng, L.; Zhu, H.; Chen, Z.; Liang, Y.X.; She, Q. Unmarked gene deletion and host–vector system for the hyperthermophilic crenarchaeon Sulfolobus islandicus. Extremophiles 2009, 13, 735–746. [Google Scholar] [CrossRef] [PubMed]
  45. She, Q.; Zhang, C.; Deng, L.; Peng, N.; Chen, Z.; Liang, Y.X. Genetic analyses in the hyperthermophilic archaeon Sulfolobus islandicus. Biochem. Soc. Trans. 2009. [Google Scholar] [CrossRef] [PubMed]
  46. Quax, T.E.F.; Lucas, S.; Reimann, J.; Pehau-Arnaudet, G.; Prevost, M.-C.; Forterre, P.; Albers, S.-V.; Prangishvili, D. Simple and elegant design of a virion egress structure in Archaea. Proc. Natl. Acad. Sci. USA 2011. [Google Scholar] [CrossRef] [PubMed]
  47. Bize, A.; Karlsson, E.A.; Ekefjärd, K.; Quax, T.E.F.; Pina, M.; Prevost, M.-C.; Forterre, P.; Tenaillon, O.; Bernander, R.; Prangishvili, D. A unique virus release mechanism in the Archaea. Proc. Natl. Acad. Sci. USA 2009, 106, 11306–11311. [Google Scholar] [CrossRef] [PubMed][Green Version]
  48. He, F.; Chen, L.; Peng, X. First experimental evidence for the presence of a CRISPR toxin in Sulfolobus. J. Mol. Biol. 2014. [Google Scholar] [CrossRef]
  49. Quax, T.E.F.; Voet, M.; Sismeiro, O.; Dillies, M.; Jagla, B.; Coppee, J.-Y.; Sezonov, G.; Forterre, P.; van der Oost, J.; Lavigne, R.; Prangishvili, D. Massive Activation of Archaeal Defense Genes during Viral Infection. J. Virol. 2013, 87, 8419–8428. [Google Scholar] [CrossRef][Green Version]
  50. Okutan, E.; Deng, L.; Mirlashari, S.; Uldahl, K.; Halim, M.; Liu, C.; Garrett, R.A.; She, Q.; Peng, X. Novel insights into gene regulation of the rudivirus SIRV2 infecting Sulfolobus cells. RNA Biol. 2013, 10, 875–885. [Google Scholar] [CrossRef][Green Version]
  51. Juhala, R.J.; Ford, M.E.; Duda, R.L.; Youlton, A.; Hatfull, G.F.; Hendrix, R.W. Genomic sequences of bacteriophages HK97 and HK022: Pervasive genetic mosaicism in the lambdoid bacteriophages. J. Mol. Biol. 2000. [Google Scholar] [CrossRef]
  52. Bettstetter, M.; Peng, X.; Garrett, R.A.; Prangishvili, D. AFV1, a novel virus infecting hyperthermophilic archaea of the genus Acidianus. Virology 2003. [Google Scholar] [CrossRef]
  53. Haring, M.; Rachel, R.; Peng, X.; Garrett, R.A.; Prangishvili, D. Viral Diversity in Hot Springs of Pozzuoli, Italy, and Characterization of a Unique Archaeal Virus, Acidianus Bottle-Shaped Virus, from a New Family, the Ampullaviridae. J. Virol. 2005. [Google Scholar] [CrossRef] [PubMed]
  54. Khayat, R.; Tang, L.; Larson, E.T.; Lawrence, C.M.; Young, M.; Johnson, J.E. Structure of an archaeal virus capsid protein reveals a common ancestry to eukaryotic and bacterial viruses. Proc. Natl. Acad. Sci. USA 2005. [Google Scholar] [CrossRef] [PubMed]
  55. Gudbergsdóttir, S.R.; Menzel, P.; Krogh, A.; Young, M.; Peng, X. Novel viral genomes identified from six metagenomes reveal wide distribution of archaeal viruses and high viral diversity in terrestrial hot springs. Environ. Microbiol. 2016. [Google Scholar] [CrossRef] [PubMed]
  56. Arnold, H.P.; Zillig, W.; Ziese, U.; Holz, I.; Crosby, M.; Utterback, T.; Weidmann, J.F.; Kristjanson, J.K.; Klenk, H.P.; Nelson, K.E.; Fraser, C.M. A novel lipothrixvirus, SIFV, of the extremely thermophilic crenarchaeon Sulfolobus. Virology 2000. [Google Scholar] [CrossRef] [PubMed]
  57. Larson, E.T.; Eilers, B.J.; Reiter, D.; Ortmann, A.C.; Young, M.J.; Lawrence, C.M. A new DNA binding protein highly conserved in diverse crenarchaeal viruses. Virology 2007. [Google Scholar] [CrossRef]
  58. Keller, J.; Leulliot, N.; Cambillau, C.; Campanacci, V.; Porciero, S.; Prangishvilli, D.; Forterre, P.; Cortez, D.; Quevillon-Cheruel, S.; Van Tilbeurgh, H. Crystal structure of AFV3-109, a highly conserved protein from crenarchaeal viruses. Virol. J. 2007. [Google Scholar] [CrossRef]
Viruses 10 00695 g001 550
Figure 1. Knockout of the non-essential gene SIRV2 gp29 by using anti-CRISPR-based genome editing. (A) Schematic illustration of the recombination (double crossover) between SIRV2M and acrID1 fragment (black arrow) cloned between the homologous arms (green and blue boxes) in pJET1.2. Genes are depicted by arrows. F1/R1 primers, which are indicated by dark red arrows above the genome map, amplify a region covering the deletion target while F2/R2, which is depicted in gold, amplify a region within the deletion target (red arrow). (B) PCR analysis of the recombination events as depicted in (A) where the size of PCR fragments is also indicated. Supernatants of the cultures containing the plasmid (acrID1) two days post electroporation (left panel) and two days post dilution (1000 times into fresh LAL14/1 ΔpyrF cells) (right panel) were used as a DNA template in the PCR reactions. Control 1, water was electroporated into the cells but no SIRV2M was added. In control 2, water was electroporated into the cells after the SIRV2M was added. The PCR bands derived from recombinant viruses are labeled with white asterisks. (C) PCR verification of gene deletion in SIRV2MΔgp29 after two more times dilution (1000 times into fresh LAL14/1 ΔpyrF cells). PCR was conducted with “Δgp29 check primers” (Table S1) using supernatant from the culture carrying SIRV2MΔgp29 (Δgp29). +, positive control using the SIRV2M virion as the PCR template, − as a negative control in “control 2” in (B), L as a DNA size ladder.
Figure 1. Knockout of the non-essential gene SIRV2 gp29 by using anti-CRISPR-based genome editing. (A) Schematic illustration of the recombination (double crossover) between SIRV2M and acrID1 fragment (black arrow) cloned between the homologous arms (green and blue boxes) in pJET1.2. Genes are depicted by arrows. F1/R1 primers, which are indicated by dark red arrows above the genome map, amplify a region covering the deletion target while F2/R2, which is depicted in gold, amplify a region within the deletion target (red arrow). (B) PCR analysis of the recombination events as depicted in (A) where the size of PCR fragments is also indicated. Supernatants of the cultures containing the plasmid (acrID1) two days post electroporation (left panel) and two days post dilution (1000 times into fresh LAL14/1 ΔpyrF cells) (right panel) were used as a DNA template in the PCR reactions. Control 1, water was electroporated into the cells but no SIRV2M was added. In control 2, water was electroporated into the cells after the SIRV2M was added. The PCR bands derived from recombinant viruses are labeled with white asterisks. (C) PCR verification of gene deletion in SIRV2MΔgp29 after two more times dilution (1000 times into fresh LAL14/1 ΔpyrF cells). PCR was conducted with “Δgp29 check primers” (Table S1) using supernatant from the culture carrying SIRV2MΔgp29 (Δgp29). +, positive control using the SIRV2M virion as the PCR template, − as a negative control in “control 2” in (B), L as a DNA size ladder.
Viruses 10 00695 g001
Viruses 10 00695 g002 550
Figure 2. Knockout of the essential gene SIRV2 gp49 by using the anti-CRISPR-based genome editing. (A) Right panel: schematic illustration of the recombination (double crossover) between SIRV2M and acrID1 fragment (black arrow) cloned between the homologous arms (green and blue boxes) in pJET1.2. Genes are depicted by arrows. F3/R3 primers, which are indicated by dark red arrows above the genome map, amplify a region covering the deletion target while F4 (depicted in gold)/R3 amplify a region from the deletion target (red arrow). The gp49-containing plasmid (pgp49, left panel) was transformed into the cells prior to the knockout experiment. (B) PCR analysis of the recombination events as depicted in (A) where the size of the PCR fragments is also indicated. Supernatants of the cultures two days post electroporation with the acrID1-containing pJET1.2 plasmid (left panel) and two days post dilution (1000 times into fresh LAL14/1 ΔpyrF/pgp49 cells) (right panel) were used as the DNA template in the PCR reactions (acrID1). Control 1: water was electroporated into the cells but no SIRV2M was added. Control 2: water was electroporated into the cells after which SIRV2M was added. The PCR bands derived from recombinant viruses are labeled with white asterisks. (C) PCR verification of gene deletion in SIRV2MΔgp49 after two more times dilution (1000 times into fresh LAL14/1 ΔpyrF/pgp49 cells). PCR was conducted with “Δgp49 check primers” (Table S1) using supernatant from SIRV2MΔgp49-containing cells (Δgp49). (+) positive control using SIRV2M virion as the PCR template; −, negative control as “control 2” in (B) L, DNA size ladder.
Figure 2. Knockout of the essential gene SIRV2 gp49 by using the anti-CRISPR-based genome editing. (A) Right panel: schematic illustration of the recombination (double crossover) between SIRV2M and acrID1 fragment (black arrow) cloned between the homologous arms (green and blue boxes) in pJET1.2. Genes are depicted by arrows. F3/R3 primers, which are indicated by dark red arrows above the genome map, amplify a region covering the deletion target while F4 (depicted in gold)/R3 amplify a region from the deletion target (red arrow). The gp49-containing plasmid (pgp49, left panel) was transformed into the cells prior to the knockout experiment. (B) PCR analysis of the recombination events as depicted in (A) where the size of the PCR fragments is also indicated. Supernatants of the cultures two days post electroporation with the acrID1-containing pJET1.2 plasmid (left panel) and two days post dilution (1000 times into fresh LAL14/1 ΔpyrF/pgp49 cells) (right panel) were used as the DNA template in the PCR reactions (acrID1). Control 1: water was electroporated into the cells but no SIRV2M was added. Control 2: water was electroporated into the cells after which SIRV2M was added. The PCR bands derived from recombinant viruses are labeled with white asterisks. (C) PCR verification of gene deletion in SIRV2MΔgp49 after two more times dilution (1000 times into fresh LAL14/1 ΔpyrF/pgp49 cells). PCR was conducted with “Δgp49 check primers” (Table S1) using supernatant from SIRV2MΔgp49-containing cells (Δgp49). (+) positive control using SIRV2M virion as the PCR template; −, negative control as “control 2” in (B) L, DNA size ladder.
Viruses 10 00695 g002
Viruses 10 00695 g003 550
Figure 3. Growth curves showing the non-essentiality of gp29 and the essentiality of gp49. (A) LAL14/1: ∆pyrF cells were transformed with an empty vector. (B) LAL14/1—pgp49: ∆pyrF cells transformed with pgp49. Virus was added at time 0. No virus was added in the control culture.
Figure 3. Growth curves showing the non-essentiality of gp29 and the essentiality of gp49. (A) LAL14/1: ∆pyrF cells were transformed with an empty vector. (B) LAL14/1—pgp49: ∆pyrF cells transformed with pgp49. Virus was added at time 0. No virus was added in the control culture.
Viruses 10 00695 g003
Viruses 10 00695 g004 550
Figure 4. The schematic diagram of the CRISPR-based genome editing approach. The spacer and the donor DNA are cloned into pGE1 (blue rectangle) and transformed into S. islandicus LAL14/1 Δarrays cells. The cells are infected with the targeted virus. The homologous recombination (double-crossover) between the virus and the donor DNA generates the desired deletion allele in the viral genome. The crRNA produced from the plasmid-borne mini-CRISPR array is assembled with the endogenous Cas proteins into the CRISPR ribonucleoprotein (crRNP) complex that directs the cleavage of non-recombinant viruses, which are those still harboring the protospacer. Conversely, the recombinant viruses are not targeted and are able to propagate.
Figure 4. The schematic diagram of the CRISPR-based genome editing approach. The spacer and the donor DNA are cloned into pGE1 (blue rectangle) and transformed into S. islandicus LAL14/1 Δarrays cells. The cells are infected with the targeted virus. The homologous recombination (double-crossover) between the virus and the donor DNA generates the desired deletion allele in the viral genome. The crRNA produced from the plasmid-borne mini-CRISPR array is assembled with the endogenous Cas proteins into the CRISPR ribonucleoprotein (crRNP) complex that directs the cleavage of non-recombinant viruses, which are those still harboring the protospacer. Conversely, the recombinant viruses are not targeted and are able to propagate.
Viruses 10 00695 g004
Viruses 10 00695 g005 550
Figure 5. Genome maps of the representative Rudiviridae members SIRV2, SIRV1, SRV, ARV1, and the smallest knockout mutant SIRV2MVII. Each gene is indicated by a block arrow and their orientation indicates the direction of transcription. Core genes among the Rudiviridae family are color-coded while additional genes are shared among SIRVs (in black). Some of these are also present in SRV. SIRV accessory genes are indicated in grey. The white arrow represents gp25, which may not be a real gene. Annotations or predicted functions (if available) for genes are indicated.
Figure 5. Genome maps of the representative Rudiviridae members SIRV2, SIRV1, SRV, ARV1, and the smallest knockout mutant SIRV2MVII. Each gene is indicated by a block arrow and their orientation indicates the direction of transcription. Core genes among the Rudiviridae family are color-coded while additional genes are shared among SIRVs (in black). Some of these are also present in SRV. SIRV accessory genes are indicated in grey. The white arrow represents gp25, which may not be a real gene. Annotations or predicted functions (if available) for genes are indicated.
Viruses 10 00695 g005
Viruses 10 00695 g006 550
Figure 6. Knockout of accessory genes from SIRV2MII by means of the CRISPR-based genome editing. (A) Schematic diagram of the PCR strategy used for screening of mutated gene alleles. F5/R5 primers —indicated by dark red arrows above the genome map—amplify a region covering the deletion target while F6/R6—depicted in gold—amplify a region within the deletion target. Homologous recombination with the donor DNA originates a deletion in the target gene by turning the input virus (a) into a deletion mutant (b). Genes are indicated by block arrows. (B) PCR amplification of target gene regions using the supernatant of infected cultures as a template. a, WT-target gene—SIRV2MII as a template— b, deletion mutant allele—SIRV2MVII as a template— c, negative control—water instead of virus template— 0, SIRV2M as a template. The corresponding amplified region is indicated on top of the gel. DNA size ladders (L) with the sizes of selected bands are shown. Primers listed in Table S1 were used.
Figure 6. Knockout of accessory genes from SIRV2MII by means of the CRISPR-based genome editing. (A) Schematic diagram of the PCR strategy used for screening of mutated gene alleles. F5/R5 primers —indicated by dark red arrows above the genome map—amplify a region covering the deletion target while F6/R6—depicted in gold—amplify a region within the deletion target. Homologous recombination with the donor DNA originates a deletion in the target gene by turning the input virus (a) into a deletion mutant (b). Genes are indicated by block arrows. (B) PCR amplification of target gene regions using the supernatant of infected cultures as a template. a, WT-target gene—SIRV2MII as a template— b, deletion mutant allele—SIRV2MVII as a template— c, negative control—water instead of virus template— 0, SIRV2M as a template. The corresponding amplified region is indicated on top of the gel. DNA size ladders (L) with the sizes of selected bands are shown. Primers listed in Table S1 were used.
Viruses 10 00695 g006
Viruses 10 00695 g007 550
Figure 7. Effect of the deletions on viral infectivity. ∆arrays cells were infected with SIRV2 and all the deletion mutants individually at a MOI of 0.1 and the virus titer (PFU/mL) of the cultures were measured with a plaque assay at 0, 12, and 24 hpi. Results from three technical replicates are shown and error bars indicate the corresponding standard deviation of the mean for the three technical replicates. PFU/mL is plotted in a logarithmic scale.
Figure 7. Effect of the deletions on viral infectivity. ∆arrays cells were infected with SIRV2 and all the deletion mutants individually at a MOI of 0.1 and the virus titer (PFU/mL) of the cultures were measured with a plaque assay at 0, 12, and 24 hpi. Results from three technical replicates are shown and error bars indicate the corresponding standard deviation of the mean for the three technical replicates. PFU/mL is plotted in a logarithmic scale.
Viruses 10 00695 g007
Table
Table 1. SIRV2 and its derivative deletion mutants obtained in previous and present studies. The code number associated to each deletion mutant is indicated. The deletion of the genes is shown in the order at which they were obtained. The precise position of the deletions is indicated by using the SIRV2 genome as a reference. The size of the deletion is also shown.
Table 1. SIRV2 and its derivative deletion mutants obtained in previous and present studies. The code number associated to each deletion mutant is indicated. The deletion of the genes is shown in the order at which they were obtained. The precise position of the deletions is indicated by using the SIRV2 genome as a reference. The size of the deletion is also shown.
VirusPosition of New Deletion (bp)Deletion Size (bp)Reference
SIRV2--
SIRV2M: Δgp02–09,51–53Δ1491–5474, Δ32426–339393983, 1513[29]
SIRV2MII: Δgp02–09,51–53,48,10–14Δ30803-31479, Δ5678–8557676, 2879Bhoobalan-Chitty unpublished
SIRV2MIII: Δgp02–09,51–53,48,10–14,22–23Δ12664–13395731This work
SIRV2MIV: Δgp02–09,51–53,48,10–14,22–23,45–47Δ29630–30517888This work
SIRV2MV: Δgp02–09,51–53,48,10–14,22–23,45–47,50Δ32169–32344175This work
SIRV2MVI: Δgp02–09,51–53,48,10–14,22–23,45–47,50,29Δ15827–16366539This work
SIRV2MVII: Δgp02–09,51–53,48,10–14,22–23,45–47,50,29,37Δ19910–20119209This work

Share and Cite

MDPI and ACS Style

Mayo-Muñoz, D.; He, F.; Jørgensen, J.B.; Madsen, P.K.; Bhoobalan-Chitty, Y.; Peng, X. Anti-CRISPR-Based and CRISPR-Based Genome Editing of Sulfolobus islandicus Rod-Shaped Virus 2. Viruses 2018, 10, 695. https://doi.org/10.3390/v10120695

AMA Style

Mayo-Muñoz D, He F, Jørgensen JB, Madsen PK, Bhoobalan-Chitty Y, Peng X. Anti-CRISPR-Based and CRISPR-Based Genome Editing of Sulfolobus islandicus Rod-Shaped Virus 2. Viruses. 2018; 10(12):695. https://doi.org/10.3390/v10120695

Chicago/Turabian Style

Mayo-Muñoz, David, Fei He, Jacob Bruun Jørgensen, Poul Kári Madsen, Yuvaraj Bhoobalan-Chitty, and Xu Peng. 2018. "Anti-CRISPR-Based and CRISPR-Based Genome Editing of Sulfolobus islandicus Rod-Shaped Virus 2" Viruses 10, no. 12: 695. https://doi.org/10.3390/v10120695

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop